ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 147

Fatigue, Coping, Sleeping Disorders and Productivity Were Still Not Frequently Reported in Rheumatoid Arthritis Trials Published in 2014-2015: A Systematic Literature Review

Levent Kilic1, Abdulsamet Erden1, Laure Gossec2 and Umut Kalyoncu1, 1Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Rheumatology, Pitié Salpetriere Hospital, Paris, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: patient outcomes and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Health Services Research Poster I: Diagnosis, Management and Treatment Strategies

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: In a systematic literature review (SLR), frequency of patients reported outcomes (PROs) related with rheumatoid arthritis (RA) was evaluated between 2005 and 2007 (1). Relatively low frequent outcome measures at this SLR were fatigue, utility, psychological status, coping, sleeping disturbance, productivity losses, wellbeing and leisure. Although pain and function are essential domains for patients, priority of patients also include fatigue, emotional well-being, sleep, coping and physical well-being (2). Objective of this study was to assess frequency and changing trend of PROs related with RA at the last 2 years.

Methods: Literature search was performed in PUBMED MEDLINE database on 01 January 2015. Publications were identified through a search that used the following exploded MeSH term: (‘‘arthritis, rheumatoid’’ (MeSH)) with a limitation to ‘‘humans’’, ‘‘all adults: 19+ years’’, ‘‘English’’, ‘‘published in the last 2 years’’ and ‘‘clinical trials’’. Publications were limited to articles referenced in PUBMED in the last 2 years. Demographic characteristics of patients, study design, treatments assessed and all PROs assessed. Results were compared with previous SLR (1).

Results:Of the 479 publications identified by the literature search, 250 were included in the analysis. Of the 250 publications, 113 (45.2%) were randomized controlled trials. One hundred-forty different tools were reported in this SLR. Function (83.4% vs 68.0%), pain (55.9% vs 40.0%), patient global assessment (63.3% vs 49.2%) and quality of life (19.2% vs 18.4%) were still essential PROs. Frequency of fatigue (13.7 vs 14.4), psychological status (7.3 vs 9.6), productivity losses (5.5 vs 6.4) and sleeping disturbance (1.8 vs 2.4) were not changed over time. On the other hand, frequency of morning stiffness (26.6 vs 10.0), coping (6.4% vs 2.0%) and utility (16.5 vs 5.2) were decreased. Although fatigue assessed with valid tools (VAS 7.2%, FACIT 4.8%), other less frequent domains (psychological status, productivity losses, sleeping disturbance, coping) did not have constant and specific tools for RA.

Conclusion: Eight years later, we still did not determine any significant change about PROs in RA trials. Priority of patients, for instance fatigue, psychological status, productivity losses, sleeping disturbance, coping were not sufficiently appear RA trials. One of the major challenge of those PROs was also related with tools. Tools about psychological status, productivity losses, sleeping disturbance and coping had high heterogeneity and low specificity for RA.

Ref:

  1. Kalyoncu U, Dougados M, Daurès JP, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature. Ann Rheum Dis. 2009;68:183-90.
  2. Gossec L, Dougados M, Rincheval N et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis. 2009;68:1680-5.

Disclosure: L. Kilic, None; A. Erden, None; L. Gossec, None; U. Kalyoncu, None.

To cite this abstract in AMA style:

Kilic L, Erden A, Gossec L, Kalyoncu U. Fatigue, Coping, Sleeping Disorders and Productivity Were Still Not Frequently Reported in Rheumatoid Arthritis Trials Published in 2014-2015: A Systematic Literature Review [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/fatigue-coping-sleeping-disorders-and-productivity-were-still-not-frequently-reported-in-rheumatoid-arthritis-trials-published-in-2014-2015-a-systematic-literature-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fatigue-coping-sleeping-disorders-and-productivity-were-still-not-frequently-reported-in-rheumatoid-arthritis-trials-published-in-2014-2015-a-systematic-literature-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology